CompletedNot Applicable

Collaboration Leading to Addiction Treatment and Recovery From Other Stresses

United States729 participantsStarted 2021-01-08

Plain-language summary

Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO) is a five-year project that tests whether delivering care using a collaborative model helps patients with both opioid use disorders and mental health disorders.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 and older * Receiving primary care at one of the participating clinical sites * Has OUD and one or more specific co-occurring behavioral health disorders (depression and PTSD) Exclusion Criteria: * Under 18 * Does not speak English or Spanish * Unable to consent * Receiving both MOUD and psychotropic medication from a provider outside of the primary care health system at which the patient is enrolled * Not receiving primary care at one of the participating clinical sites

What they're measuring

Buprenorphine access

Timeframe: Assessed at 6 months after study entry.

Buprenorphine continuity of care

Timeframe: Assessed at 6 months after study entry.

Major Depressive Disorder (MDD) symptom severity

Timeframe: Assessed at 6 months after study entry.

Post-traumatic Stress Disorder (PTSD) symptom severity

Timeframe: Assessed at 6 months after study entry.

Trial details

NCT IDNCT04559893

SponsorRAND

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-12

View on ClinicalTrials.gov More Opioid-use Disorder trials